Dr. Olumuyiwa Adesina Owolabi

11owolabi TB Sequel Project - Research, Capacity Development, Networking


Dr. Olumuyiwa Owolabi plays a pivotal role in the project at MRC Gambia at LSHTM, where his main responsibilities include coordinating field activities at the public health clinic. Here, potential study participants are approached, sensitized, and consented for enrolment into TB sequel studies. He also performs extensive clinical assessments required at each clinical visit and follow-up, adhering strictly to the ICH-E6 Good Clinical Practice (GCP) guidelines.

Educated in Nigeria, Dr. Owolabi completed his residency program at the University Teaching Hospital and is a consultant paediatrician (MB.BS; FMC Paed.) with an MPH from London-DL. His research interests focus primarily on infectious diseases, with a special emphasis on tuberculosis public health, nutrition, and haematology. Dr. Owolabi has a wealth of experience in clinical vaccine trials and has served as the coordinating clinician of the MRCG at LSHTM TB research platform since 2012.

Throughout his career, Dr. Olumuyiwa Owolabi has published and co-authored numerous papers on Tuberculosis research, covering a wide range of topics from vaccine trials and biomarker discovery to monitoring treatment responses. His work has significantly contributed to understanding vitamin D’s role in TB patients in The Gambia, as well as the safety and immunogenicity of two novel candidate TB vaccines.

Contact Info